Increasing cerebrospinal fluid tau levels in a subgroup of Alzheimer patients with apolipoprotein E allele ε4 during 14 months follow-up

Neuroscience Letters

Volumn 214, Issue 2-3, 1996, Pages 163-166

  Blomberg, Mari ^a   Jensen, Malene ^a   Basun, Hans ^a   Lannfelt, Lars ^a   Wahlund, Lars Olof ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Alzheimer's disease; Apolipoprotein E genotype; Biological marker; Cerebrospinal fluid; Diagnosis; Tau protein

Indexed keywords

APOLIPOPROTEIN E; APOLIPOPROTEIN E4; TAU PROTEIN;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CEREBROSPINAL FLUID; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; MALE; PRIORITY JOURNAL;

EID: 0030599039     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/0304-3940(96)12905-0     Document Type: Article

References (18)

1. [1] American Psychiatric Association, Diagnostic and Statistical Manual of Mental Disorders, 4th Edn., American Psychiatric Association, Washington DC, 1994, 142 p.
2. [2] Arai, H., Terajima, M., Miura, M., Higuchi, S., Muramatsu, T., Machida, N., Seiki, H., Takase, S., Clark, C.M., Lee, V.M.Y., Trojanowski, J.Q. and Sasaki, H., Tau in cerebrospinal fluid: a potential diagnostic marker in Alzheimer's disease, Ann. Neurol., 38 (1995) 649-652.
3. [3] Basun, H., Corder, E.H., Guo, Z., Lannfelt, L., Corder, L.S., Manton, K.G., Winblad, B. and Viitanen, M., APOE polymorphism is not a risk factor for cognitive impairment and haemorrhagic stroke from age 75 onwards, Stroke, (1996) in press.
4. [4] Folstein, M.F., Folstein, S.E. and McHugh, P.R., Mini mental state: a practical method for grading the cognitive state of patients for the clinician, J. Psychiat. Res., 12 (1975) 189-198.
5. [5] Goedert, M., Tau protein and the neurofibrillary pathology of Alzheimer's disease, Trends. Neurol. Sci., 11 (1993) 460-465.
6. [6] Hughes, C.P., Berg, L., Danziger, W.L., Coben, L.A. and Martin, R.L., A new clinical scale for the staging of dementia, Br. J. Psychiatry, 140 (1982) 566-572.
7. [7] Jensen, M., Basun, H. and Lannfelt, L., Increased cerebrospinal fluid tau in patients with Alzheimer's disease, Neurosci. Lett., 186 (1995) 189-191.
8. [8] Lee, V.M.Y., Balin, B.J., Otvos, L. and Trojanowski, J.Q., A 68: a major subunit of paired helical filaments and derivatized forms of normal tau, Science, 251 (1991) 675-678.
9. [9] McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D. and Stadlan, E.M., Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease, Neurology, 34 (1984) 939-944.
10. [10] Morris, J.C., The clinical dementia rating (CDR): current version and scoring rules, Neurology, 43 (1993) 2412-2414.
11. [11] Mullan, M., Crawford, F., Axelman, K., Houlden, H., Lilius, L., Winblad, B. and Lannfelt, L., A pathogenic mutation for probable Alzheimer's disease in the APP gene at the N-terminus of β-amyloid, Nature Genet., 1 (1992) 345-347.
12. [12] Munroe, W.A., Southwick, P.C., Chang, L., Scharre, D.W., Echols, C.L. Jr., Fu, P.C., Whaley, J.M. and Wolfert, R.L., Tau protein in cerebrospinal fluid as an aid in the diagnosis of Alzheimer's disease, Ann. Clin. Lab. Sci., 25 (1995) 207-216.
13. [13] Román, G.C., Tatemichi, T.K., Erkinjuntti, T., Cummings, J.L., Masdeu, J.C., Garcia, J.H., Amaducci, L., Orgogozo, J.M., Brun, A., Hofman, A., Moody, D.M., O'Brien, M.D., Yamaguchi, T., Grafman, J., Drayer, B.P., Bennett, D.A., Fisher, M., Ogata, J., Kokmen, E., Bermejo, F., Wolf, P.A., Gorelick, P.B., Bick, K.L., Pajeau, A.K., Bell, M.A., Phil, D., DeCarli, C., Culebras, A., Korczyn, A.D., Bogousslavsky, J., Hartmann, A. and Sceinberg, P., Vascular dementia: diagnostic criteria for research studies, report of the NINDS-AIREN international workshop, Neurology, 43 (1993) 250-260.4.
14. [14] Strittmatter, W.J., Saunders, A.M., Goedert, M., Weisgraber, K.H., Dong, L.-M., Jakes, R., Huang, Y., Pericak-Vance, M., Schmechel, D. and Roses, A.D., Isoform-specific interactions of apolipoprotein E with microtubule-associated protein tau: implications for Alzheimer's disease, Proc. Natl. Acad. Sci. USA, 91 (1994) 11183-11186.
15. [15] Strittmatter, W.J. and Roses, A.D., Apolopoprotein E and Alzheimer's disease, Proc. Natl. Acad. Sci. USA, 92 (1995) 4725-4727.
16. [16] Tierney, M.C., Szalai, J.P., Snow, W.G., Fisher, R.H., Nores, A., Nadon, G., Dunn, E. and St Georges-Hyslop, P.H., Prediction of probable Alzheimer's disease in memory-impaired patients: a prospective longitudinal study, Neurology, 46 (1996) 661-665.
17. [17] Vandermeeren, M., Mercken, M., Vanmechelen, E., Six, J., Van de Vorde, A., Martin, J.-J. and Cras, P., Detection of τ proteins in normal and Alzheimer's disease cerebrospinal fluid with a sensitive sandwich enzyme linked immunoabsorbant assay, J. Neurochem., 61 (1993) 1828-1834.
18. [18] World Health Organization, The ICD 10 classification of mental and behavioral disorders, diagnostic criteria for research, World Health Organization, Geneva, 1993, pp. 29, 30, 35.